FDA Drug · D-0713-2026

Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only, Rx Only, Distributed by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-760-01.

Class III · Ongoing

Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Affected lots / codes — check yours against thisLot: 070126X1, Exp. 12/31/2027.

Recalling firm: Asclemed USA Inc., Torrance, CA
Classification: Class III (unlikely to cause harm)
Status: Ongoing
Quantity: 18 kits
Distribution: Within U.S. - Tennessee
Recall initiated: July 15, 2026
Classified: July 20, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0713-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →